SCHEMBL560478

SCHEMBL560478

CCCCCCc1cc(Cl)ccc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
CYP3A4 P08684 3/20 0.55
ALOX15 P16050 3/20 0.55
HTT P42858 3/20 0.55
HIF1A Q16665 3/20 0.55
HPGD P15428 3/20 0.55
MAPT P10636 2/20 0.55
HSP90AA1 P07900 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
SLC22A1 O15245 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
HSPD1 P10809 1/20 0.55
HSPA5 P11021 1/20 0.55
IDO1 P14902 1/20 0.55
ALOX12 P18054 1/20 0.55
CASP1 P29466 1/20 0.55
BLM P54132 1/20 0.55
HSPE1 P61604 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38662001 1.00 MEN1 (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL8329001 1.00 MEN1 (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL29810168 1.00 MEN1 (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL631979 1.00 MEN1 (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL573986 1.00 MEN1 (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL574412 0.98 ALOX15 (0.57) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL8592391 0.96 ALOX15 (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL573716 0.93 ALOX15 (0.59) MEN1KMT2ACYP3A4ALOX15HTT
Heptane SCHEMBL11365624 0.86 HIF1A (0.55) MEN1KMT2ACYP3A4ALOX15HTT
SCHEMBL630770 0.85 HIF1A (0.63) MEN1KMT2ACYP3A4ALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 615 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140135297-A1 AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION ISP INVESTMENTS INC. (US) 2014-05-15 US claimed
CN-101267734-B Disinfectant comprising a combination of a biocidal phenol and a keratolytic agent BAYER HEALTHCARE LLC 2012-05-30 CN claimed
EP-2313026-A1 ACTIVE DELIVERY SYSTEM FORMULATIONS Castle Beach, L.L.C. (US) 2011-04-27 EP claimed
US-20110086823-A1 DISINFECTANT BAYER ANIMAL HEALTH GMBH (DE) 2011-04-14 US claimed
US-20100040565-A1 ACTIVE DELIVERY SYSTEMS FORMULATIONS Castle Beach, LLC (US) 2010-02-18 US claimed
WO-2010019680-A1 ACTIVE DELIVERY SYSTEM FORMULATIONS HOMOLA ANDREW M (US) 2010-02-18 WO claimed
EP-1549731-B1 CLEANING AND DISINFECTING COMPOSITION RECKITT BENCKISER INC (US) 2008-12-17 EP claimed
CN-101267734-A Disinfecting agent containing a combination of biocidal phenols and a keratolytic BAYER HEALTHCARE LLC (DE) 2008-09-17 CN claimed
US-20080221222-A1 Disinfectant BAYER HEALTHCARE LLC (DE) 2008-09-11 US claimed
EP-1909569-A2 DISINFECTING AGENT CONTAINING A COMBINATION OF BIOCIDAL PHENOLS AND A KERATOLYTIC Bayer HealthCare AG (DE) 2008-04-16 EP claimed
US-20060093570-A1 Surface treatment RECKITT BENCKISER (UK) LIMITED (GB) 2006-05-04 US claimed
US-20060040847-A1 Hard surface treating compositions RECKITT BENCKISER INC. 2006-02-23 US claimed
US-20060034880-A1 Cleaning and disinfecting composition RECKITT BENCKISER INC (US) 2006-02-16 US claimed
US-20050233930-A1 Disinfectant cleaning compositions RECKITT BENCKISER INC. (US) 2005-10-20 US claimed
EP-1549731-A1 CLEANING AND DISINFECTING COMPOSITION Reckitt Benckiser Inc. (US) 2005-07-06 EP claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 EP claimed
EP-0805672-B1 METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH HOMOLA ANDREW M (US) 2004-08-25 EP claimed
WO-2004035724-A1 CLEANING AND DISINFECTING COMPOSITION RECKITT BENCKISER INC (US) 2004-04-29 WO claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 WO claimed
US-5665333-A Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth PROVSEAL LLC 1997-09-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040565-A1 ACTIVE DELIVERY SYSTEMS FORMULATIONS LIPA, MMP7, CTSA MEN1 4098/4885KMT2A 4226/4885CYP3A4 1524/4885
US-20060034880-A1 Cleaning and disinfecting composition APOBEC3G, APOBEC3C, APOBEC3B MEN1 2067/4885KMT2A 2948/4885CYP3A4 3833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.